CreditReports.dk
HomeScreen companies

PHARMA MEDICO ApS Financials, key figures and credit report

CVR number: 28665741 Established 2006 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Hans Hartvig Seedorffs Stræde 12, 8000 Aarhus C www.pharmamedico.com
Gross profit 32 265.7 kDKK FY 2025 +49.5% vs 2024
EBIT 20 270.2 kDKK FY 2025 +93.6% vs 2024
Net debt -28 653.5 kDKK FY 2025 -8.1% vs 2024
Quick ratio 5.0 FY 2025 -1.8 vs 2024

Company information

Official name
PHARMA MEDICO ApS
Personnel
11 persons
Established
2006
Company form
Private limited company
Industry

Data sources and methodology

The information about PHARMA MEDICO ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Open the 2025 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About PHARMA MEDICO ApS

PHARMA MEDICO ApS (CVR number: 2866574-1) is a company from AARHUS. The company recorded a gross profit of 32.3 mDKK in 2025. The operating profit was 20.3 mDKK, while net earnings were 15.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was 26.1 %, which can be considered excellent and Return on Equity (ROE) was 23.4 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 81.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. PHARMA MEDICO ApS's liquidity measured by quick ratio was 5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales
Gross profit21 547.8530 054.4226 192.9421 583.9932 265.73
EBIT11 940.7421 758.3217 217.3610 471.0920 270.17
Net earnings10 382.7316 438.0514 018.638 608.9715 407.74
Shareholders equity total39 572.8151 510.8659 529.4968 138.4663 546.19
Balance sheet total (assets)48 216.2363 766.5571 957.5779 297.5578 959.41
Net debt-11 740.55-9 515.98-26 481.86-26 511.36-28 653.52
Profitability
EBIT-%
ROA30.8 %38.9 %26.8 %15.2 %26.1 %
ROE30.2 %36.1 %25.2 %13.5 %23.4 %
ROI37.3 %46.2 %31.3 %17.3 %30.0 %
Economic value added (EVA)8 324.4614 981.9110 672.844 910.8412 134.11
Solvency
Equity ratio82.1 %80.8 %82.7 %85.9 %81.6 %
Gearing0.0 %0.6 %0.3 %0.4 %3.9 %
Relative net indebtedness %
Liquidity
Quick ratio5.14.95.76.95.0
Current ratio5.55.26.07.24.9
Cash and cash equivalents11 745.359 845.4926 666.4426 787.1231 100.47
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2025
26.1%
Rating 81/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
81.6%
Rating 61/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of PHARMA MEDICO ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated